8-K

                              
              SECURITIES AND EXCHANGE COMMISSION
                               
                    Washington, D. C. 20549
                               
                           FORM 8-K
                               
                        CURRENT REPORT
                               
                               
 Pursuant to Section 13 or 15(d) of the Securities Exchange Act
                            of 1934

              Date of Report    February 21, 1996


                    BARR LABORATORIES, INC.
    (Exact name of registrant as specified in its charter)
                               
                               
                               
                               
                               
    New York                      1-9860            22-1927534
                               
 (State or other jurisdiction   (Commission     (IRS Employer
    of  incorporation)          File Number)    Identification No.)





       Two Quaker Road, P.O. Box 2900, Pomona, New York 10970-0519

        (Address of principal executive offices)        (Zip code)


                        (914) 362-1100

     (Registrant's telephone number, including area code)









                    BARR LABORATORIES, INC.
                               
                               
            CURRENT REPORT  dated February 21, 1996
                               

Item 5. Other Events

     See  attached Exhibit 99.1, press release announcing  the
     declaration of a stock split.




Item 7. Financial Statements and Exhibits

(c)  Exhibit Number Exhibit

     99.1         Registrant's February 21, 1996 press
                  release announcing the declaration of a 3
                  for 2 stock split.







                    BARR LABORATORIES, INC.
                               
                               
            CURRENT REPORT dated February 21, 1996
                               
                               
                               
                          SIGNATURES
                               
                               
 Pursuant to the requirements of the Securities and Exchange
 Act of 1934, the registrant has duly caused this report to be
 signed on its behalf by the undersigned hereunto duly
 authorized.


                    BARR LABORATORIES, INC.
                               
                               
                               
                               








 Date:  February 21, 1996           /S/ Paul M. Bisaro
                                   Paul M. Bisaro
                                   Vice President, Chief Financial Officer,
                                   General Counsel and Corporate Secretary

EX-99

[ARTICLE] 5
                                                Exhibit 99.1


 2 Quaker Road, P.O. Box 2900       N E W S   R E L E A S E
 Pomona, NY 10970
 914-362-1100

 CONTACT: Charles M. Mayr,  914-348-8050


 Barr Laboratories Declares 3 for 2 Stock Split

 Pomona, New York, February 21, 1996...Barr Laboratories, Inc.
 (AMEX-BRL) today announced that its Board of Directors has
 approved a 3 for 2 stock split effected in the form of a 50%
 stock dividend.  Approximately 4.7 million additional shares
 of common stock will be distributed to shareholders of record
 as of March 4, 1996.  Fractional share amounts resulting from
 the split will be paid to shareholders in cash.  The Company
 set the distribution date for March 25, 1996. 

 "The stock split reflects our optimism in the future prospects
 of the Company," said Bruce L. Downey, Chairman, President and
 Chief Executive Officer.  "By splitting the stock, we reward
 our shareholders with a broader stake in Barr's potential
 success, while simultaneously lowering the stock price to a
 range that should encourage additional investment by current
 and potential shareholders.  This action will increase the
 overall number of shares available for trading, thereby
 enhancing liquidity for the individual investor." 

 Barr Laboratories, Inc. is a leading independent developer,
 manufacturer and marketer of high quality generic
 pharmaceuticals.

 [EDITOR'S ADVISORY:  Barr Laboratories, Inc. news releases are
 available free of charge through PR Newswire's News On-Call
 fax service.  For a menu of Barr's previous releases, or to
 receive a specific release via fax call :  800-758-5804 --
 ext. 089750, or use the Internet via
 http://www.prnewswire.com/cnoc/exec/menu?089750.]

 #  #  #